z-logo
open-access-imgOpen Access
RenalAT1Receptor Protein Expression During the Early Stage of Diabetes Mellitus
Author(s) -
Lisa M. HarrisonBernard,
John D. Imig,
Pamela K. Carmines
Publication year - 2001
Publication title -
journal of diabetes research
Language(s) - English
Resource type - Journals
eISSN - 2314-6753
pISSN - 2314-6745
DOI - 10.1080/15604280214483
Subject(s) - renal cortex , endocrinology , medicine , streptozotocin , angiotensin ii , renal function , kidney , nephrectomy , immunohistochemistry , nephron , chemistry , receptor , diabetes mellitus
Experiments were performed to evaluate the hypothesis that the early stage of Type 1 diabetes mellitus (DM) increases renal angiotensin II (AngII) concentration and angiotensin type 1 (AT) receptor protein levels. Nineteen or twenty days after vehicle (Sham rats) or streptozotocin (STZ rats) treatment, plasma [AngII] was higher in STZ rats (152 +/- 23 fmol/ml) than in Sham rats (101 +/- 7 fmol/ml); however, kidney [AngII] did not differ between groups. AT1 receptor protein expression was greater in STZ kidneys than in Sham kidneys. This increase was restricted to the cortex, where AT1 protein levels were elevated by 77 +/- 26% (42 kDa) and 101 +/- 16% (58 kDa) in STZ kidneys. Immunohistochemistry revealed this effect to be most evident in distal nephron segments including the connecting tubule/cortical collecting duct. Increased renal cortical AT1 receptor protein and circulating AngII levels are consistent with an exaggerated AngII-dependent influence on renal function during the early stage of DM in the rat.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom